▶주메뉴 바로가기
▶본문 바로가기
[ THE INVESTOR ] Chinese biotech firm HitGen said on April 18 that the company has entered into a multi-year research collaboration and license agreement with Pfizer to build and screen novel DNA-...
[ THE INVESTOR ] Major pharmaceutical firms saw their revenues from exports of active pharmaceutical ingredients increase last year, industry sources said on April 18. Yuhan , a major drug compan...
[ THE INVESTOR ] US private equity firm Bain Capital will acquire Hugel for about 900 billion won (US$792 million) in its latest push to expand its health care portfolio, the Korean botulinum to...
[ THE INVESTOR ] Korea’s botulinum toxic product maker Medytox is looking to acquire promising skin care firms in order to create synergies with its flagship wrinkle smoother business. “The tar...
[ THE INVESTOR ] The fight has dragged on for the past year, but the chief executive of Medytox is determined to uphold his claim that rival Daewoong Pharmaceutical stole its key ingredient to ...
[ THE INVESTOR ] Eli Lilly and Boehringer Ingelheim launched Basaglar, a biosimilar referencing Sanofi’s blockbuster insulin drug Lantus, in South Korea on April 13, intent on challenging the origi...
[ THE INVESTOR ] Genexine said on April 13 that its long-acting diabetes drug candidate has got funding of 2.1 billion won (US$1.85 million) from the Korean government. The Ministry of Health an...
[ THE INVESTOR ] Celltrion has sought approval from Japan’s Health Ministry for its biosimilar drug Herzuma, with aims to start sales in 2018. the Korean biopharmaceutical firm said on April 13. ...
[ THE INVESTOR ]The 2017 Bio Korea International Convention opened at COEX in southern Seoul for a three-day run on April 12. More than 650 bio companies from both home and abroad showcased their ...
[ THE INVESTOR ] Robert Urban, head of Johnson & Johnson Innovation, is visiting Seoul this week to meet a few biotechnology companies in Korea where the company is seeking to create a partnering ...
[ THE INVESTOR ] Hanmi Pharmaceutical on April 10 unveiled nine new drug candidates in preclinical animal testing, including those for breast and lung cancer. They are among the 23 new drugs tha...
[THE INVESTOR] At age 4, an American toddler named Nicholas Volker was dying. Since he was born, the boy had suffered from an unknown disease that caused holes to continually form in his abdomen. ...
[ THE INVESTOR ] Celltrion has maintained the top position in the pharmaceutical and biotech industry in terms of operating profit for the sixth consecutive year since 2011, industry data showed ...
[ THE INVESTOR ] South Korea’s Genexine is attracting attention from global pharmaceutical companies as its long-acting human growth hormone treatment has shown positive interim data from phase ...
[ THE INVESTOR ] Samsung BioLogics on April 3 denied allegations that it used accounting fraud to boost its valuation ahead of its public listing last year, as South Korea’s finance regulator pre...
This week's DECODED X
Samsung sends out invites for Galaxy Note 8 Unpacked
Abu Dhabi SWF invests in Nexen Tire
All you need to know about Samsung's Galaxy Note 8
Mercedes-Benz to haul diesel cars off Korean roads
Coway teams up with Amazon for hi-tech water purifier
Coupang wins lawsuit on Rocket Delivery
Samsung launches English version of Bixby in US, Korea
